SPARTHA MEDICAL COMPLETES ITS FIRST ROUND OF FUNDING TO DEVELOP ITS CUSTOMISED COATINGS OFFER (€1.4M)
Strasbourg, FRANCE, 8 Decembre 2021. SPARTHA Medical, a French MedTech company specialising in the development of multifunctional antimicrobial, antiviral and anti-inflammatory coatings, is pleased to announce that a finalised fundrasing round ouf €1.4 million by Alsace Business Angels, Yeast, WiSEED and BPI (Banque Publique d’Investissement, under instruction).
The invisible shields
Founded in 2019 and based in Strasbourg, SPARTHA Medical is a BioTech/MedTech company at the preclinical stage, resulting from the work of the National Institute of Health and Medical Research (Inserm) U1121 unit, which develops coatings based on natural biopolymers with antimicrobial, antiviral and anti-inflammatory properties.
B2B platform
A unique and personalised service based on our technology.
Medical Kit
An antibacterial and pro-regenerative kit for use during surgery.
Consumer
An innovative hygiene product, respectful of people and the environment.
We aim to become the market leader in customised coatings.
Our platform is constantly evolving thanks to the integration of artificial intelligence, allowing us to predict the best conditions to define when creating our formulations, as close as possible to the needs of the sector and/or the patient.